Company news
Uni Bio Science Group, Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
November 3, 2026
Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
October 5, 2026
Notification letter and reply form
September 18, 2026
Notification letter and request form
September 18, 2026
Interim Report 2026
September 18, 2026
Uni Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High Growth Medical Aesthetics Market
December 2, 2024
Uni Bio Science Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships
March 27, 2023
Interim Report 2022
September 11, 2022
Uni Bio Science opens Hong Kong research centre,Future R&D focus in four major businesses
June 13, 2022
2021 Annual Results—Achieved Record-High Turnover and EGF Products Recorded Strong Rebound Successful Expansion Into Ophthalmology and Other Potential Therapeutic Areas
March 21, 2022
Supplemental announcement positive profit alert
August 11, 2021
Environmental, social and governance report 2020
May 12, 2021
Uni Bio Science Group: Grant of general mandates to issue and repurchase shares, re-election of directors and notice of annual general meeting
April 26, 2021
Voluntary announcement uni-glp development in treatment of covid-19 and other indications
September 18, 2020
Interim Report 2020
September 15, 2020